As of October 2024, Aprogen pharmaceuticals has a market cap of $512.41M. This makes Aprogen pharmaceuticals the world's 11280th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $92.85M | -36.21% |
2023 | $145.54M | -42.35% |
2022 | $252.44M | -44.42% |
2021 | $454.19M | -31.18% |
2020 | $659.96M | -2.95% |
2019 | $680.03M | -25.24% |
2018 | $909.59M | -41.83% |
2017 | $1.56B | 4.73% |
2016 | $1.49B | 22.15% |
2015 | $1.22B | 290.85% |
2014 | $312.73M | -10.87% |
2013 | $350.87M | -41.99% |
2012 | $604.87M | - |